Posted by Zahid Ali on Monday, December 28, 2009,
Mesothelioma is a rare form of cancer that develops in the
mesothelial cells. These cells are tissue that surround or line the
lungs, heart, and stomach. The mesothelial cells protect these organs
by producing a lubricating fluid that allows these organs to move
smoothly. Malignant mesotheliomas arise from the cells that line
the surface of the pleura or the peritoneum. Eighty percent of these
tumors are pleural in origin. Malignant mesotheliomas are rare, with an
incidence of one to three cas... Continue reading ...
Posted by Zahid Ali on Wednesday, December 23, 2009,
Mesothelioma treatment options almost always include chemotherapy.
Chemotherapy is recommended by mesothelioma doctors to attempt to stunt
or destroy the mesothelioma cells.
Most patients who undergo mesothelioma treatments do so in order to
prolong life, or to make life as symptom free as possible while there
is still time. Most mesothelioma doctors have the unfortunate duty to
prepare their patients for the high likelihood of death.
Asbestos lawyers have joined forces with mesothelioma d... Continue reading ...
Posted by Zahid Ali on Wednesday, December 23, 2009,
Peritoneal mesothelioma is less common than pleural mesothelioma,
but both of these typically malignant mesotheliomas can be just as
tragic. Peritoneal mesothelioma begins in the abdominal cavity, as
opposed to the lungs and pleural areas of pleural mesothelioma.
“Peritoneal” means it has to do with the peritoneum, which is a
membrane that surrounds the abdominal area. “Pleural” refers to the
pleura which is a membrane that surrounds the lungs. There is also a
“pericardial” mesoth... Continue reading ...
Posted by Zahid Ali on Wednesday, December 23, 2009,
Mesothelioma stages are categorized in the medical community for
evaluative benefit for the physician, the medical institution,
participation in clinical trials, and advancements in mesothelioma
treatment options. Staging systems are used to define mesothelioma
stages; however, mesothelioma stages are far more descriptive for
pleural mesothelioma than for peritoneal mesothelioma or pericardial
mesothelioma. Mesothelioma staging systems have changed over time. As
medical knowledge increases, m... Continue reading ...
Posted by Zahid Ali on Wednesday, December 23, 2009,
Mesothelioma treatment options for malignant mesothelioma can
relieve pain and provide hope for the future. In many cases, new
mesothelioma treatment options can increase mesothelioma life
expectancy beyond original expectations. Even if advanced malignant
mesothelioma has reached a seemingly incurable stage, participating in
clinical trials gives a breath of hope to the future generations of
mesothelioma cancer patients. Treatment for malignant
mesothelioma can start with surgery, although ... Continue reading ...
Posted by Zahid Ali on Wednesday, December 23, 2009,
Mesothelioma life expectancy at the time of diagnosis will
traditionally be announced at being somewhere between a few months to
only a year or two. Statistically speaking, mesothelioma life
expectancy is frighteningly short. However, the mesothelioma life
expectancy rate is a mere average, mean or median of mesothelioma
patients with wildly different independent variables. Many of these
mesothelioma patients have lived years past their expected “date of
death” estimate. Mesothelioma tre... Continue reading ...
Posted by Zahid Ali on Wednesday, December 23, 2009,
Finding a highly qualified and competent California mesothelioma
attorney involves a little investigation. Newly diagnosed victims of
Mesothelioma in California often have ample questions involving their
health, their future, and their lawful recourses in the event of a
mesothelioma diagnosis. The facts of mesothelioma are not easy to hear,
nor are they easy to deal with. While a Mesothelioma doctor is equipped
to answer medical and health questions as they relate to Mesothelioma,
only a qual... Continue reading ...
Posted by Zahid Ali on Wednesday, December 23, 2009,
MESOSELIOMA MESOMARK BLOOD TEST
The Food and Drug Administration (FDA) approved the MESOMARK assay to help monitor response to treatment in malignant mesothelioma patients.
The MESOMARK test signifies the beginning of a new era in monitoring
mesothelioma malignancies," said Dr. W. Jeffrey Allard, vice president
and chief scientific officer of Fujirebio Diagnostics. "As the first
in-vitro test for patients with this aggressive disease, it will enable
doctors to more accurately detect recurrence... Continue reading ...
|
|